Related Experiment Video
Updated: Apr 20, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes
Charline Vauchy1, Clementine Gamonet, Christophe Ferrand
1INSERM UMR1098, F25020 Besançon cedex, France; Université de Franche-Comté, F25020 Besançon cedex, France; EFS Bourgogne Franche-Comté, F25020 Besançon cedex, France.
Abstract:
Cancer-specific splice variants gain significant interest as they generate neo-antigens that could be targeted by immune cells. CD20, a membrane antigen broadly expressed in mature B cells and in B cell lymphomas, is subject to an alternative splicing named D393-CD20 leading to loss of membrane expression of the spliced isoform. D393-CD20 expression is detectable in transformed B cells and upregulated in various lymphoma B cells. In this study, we show that D393-CD20 is translated in malignant B cells and that D393-CD20 specific CD4 T cells producing IFN-γ are present in B-cell lymphoma patients. Then, we have investigated whether the 20mer D393-CD20 peptide spanning the splicing site might be targeted by the immune system and we have shown that D393-CD20-specific CD4 Th1 clones could directly recognize malignant B cell lines and kill autologous lymphoma B cells indicating that D393-CD20-derived epitopes are naturally processed and presented on tumor cells. Finally, D393-CD20 peptide-based vaccination induced specific CD8 and CD4 T cell responses in HLA-humanized transgenic mice suggesting the presentation of D393-CD20 derived peptides on both HLA Class-I and -II. These findings support further investigations on the potential use of D393-CD20 directed specific immunotherapy in B cell malignancies.
Insights
Cancer splice variants like D393-CD20 create neo-antigens for targeted immunotherapy. This study found D393-CD20 specific T cells in lymphoma patients, suggesting its potential for treating B cell malignancies.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Cancer-specific splice variants are emerging targets for cancer immunotherapy due to neo-antigen generation.
- CD20, a B cell marker, undergoes alternative splicing (D393-CD20), resulting in loss of membrane expression and potential for immune targeting.
Purpose of the Study:
- To investigate the translation and immunogenicity of the D393-CD20 splice variant in B cell lymphomas.
- To evaluate the potential of D393-CD20-derived epitopes for cancer immunotherapy.
Main Methods:
- Detection of D393-CD20 translation in malignant B cells.
- Identification and characterization of D393-CD20 specific CD4 T cell responses (IFN-γ production) in lymphoma patients.
- Assessment of D393-CD20-specific CD4 Th1 clone recognition and killing of tumor cells.
- Evaluation of D393-CD20 peptide-based vaccination in HLA-humanized transgenic mice.
Main Results:
- D393-CD20 is translated in malignant B cells, and specific CD4 T cells are present in B-cell lymphoma patients.
- D393-CD20-specific CD4 Th1 clones recognize and kill malignant B cell lines and autologous lymphoma cells.
- Vaccination with D393-CD20 peptide elicits CD8 and CD4 T cell responses in mice, indicating presentation on HLA Class-I and -II.
Conclusions:
- D393-CD20-derived epitopes are naturally processed and presented on tumor cells.
- The D393-CD20 splice variant holds promise as a target for specific immunotherapy in B cell malignancies.
More Related Videos
08:48Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain
Published on: October 25, 2016
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
RNA Splicing
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...